The economics of stone disease.
Publication
, Journal Article
Canvasser, NE; Alken, P; Lipkin, M; Nakada, SY; Sodha, HS; Tepeler, A; Lotan, Y
Published in: World J Urol
September 2017
The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
World J Urol
DOI
EISSN
1433-8726
Publication Date
September 2017
Volume
35
Issue
9
Start / End Page
1321 / 1329
Location
Germany
Related Subject Headings
- Urology & Nephrology
- Urolithiasis
- Ureteral Calculi
- Nephrostomy, Percutaneous
- Nephrolithiasis
- Lithotripsy
- Humans
- Hospitalization
- Health Care Costs
- Cost-Benefit Analysis
Citation
APA
Chicago
ICMJE
MLA
NLM
Canvasser, N. E., Alken, P., Lipkin, M., Nakada, S. Y., Sodha, H. S., Tepeler, A., & Lotan, Y. (2017). The economics of stone disease. World J Urol, 35(9), 1321–1329. https://doi.org/10.1007/s00345-017-2003-y
Canvasser, Noah E., Peter Alken, Michael Lipkin, Stephen Y. Nakada, Hiren S. Sodha, Abdulkadir Tepeler, and Yair Lotan. “The economics of stone disease.” World J Urol 35, no. 9 (September 2017): 1321–29. https://doi.org/10.1007/s00345-017-2003-y.
Canvasser NE, Alken P, Lipkin M, Nakada SY, Sodha HS, Tepeler A, et al. The economics of stone disease. World J Urol. 2017 Sep;35(9):1321–9.
Canvasser, Noah E., et al. “The economics of stone disease.” World J Urol, vol. 35, no. 9, Sept. 2017, pp. 1321–29. Pubmed, doi:10.1007/s00345-017-2003-y.
Canvasser NE, Alken P, Lipkin M, Nakada SY, Sodha HS, Tepeler A, Lotan Y. The economics of stone disease. World J Urol. 2017 Sep;35(9):1321–1329.
Published In
World J Urol
DOI
EISSN
1433-8726
Publication Date
September 2017
Volume
35
Issue
9
Start / End Page
1321 / 1329
Location
Germany
Related Subject Headings
- Urology & Nephrology
- Urolithiasis
- Ureteral Calculi
- Nephrostomy, Percutaneous
- Nephrolithiasis
- Lithotripsy
- Humans
- Hospitalization
- Health Care Costs
- Cost-Benefit Analysis